ArticleJournal of diabetes science and technology2017
SPECTRUM.
Article in Journal of diabetes science and technology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 39 citations in OpenAlex.
- [Diabetes education and counseling in adult patients with diabetes (Update 2026)].Wiener klinische Wochenschrift · 2026Review
- Differences in Continuous Glucose Monitoring Metrics Between Prediabetes and Normoglycemia: A Systematic Review and Meta-Analysis.Journal of diabetes science and technology · 2026Review
- Advances in Continuous Glucose Monitoring: Clinical Applications.Endocrinology and metabolism (Seoul, Korea) · 2025Review
- Observational
- Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes.Endocrine connections · 2023Review
- [Diabetes education and counseling in adult patients with diabetes (Update 2023)].Wiener klinische Wochenschrift · 2023Article
- Interferences With CGM Systems: Practical Relevance?Journal of diabetes science and technology · 2022Article
- Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.Journal of diabetes science and technology · 2022Review
- Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM.Diabetes research and clinical practice · 2021Article
- Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM.Journal of diabetes science and technology · 2021Article
- An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately.Journal of diabetes science and technology · 2020Article
- Development of a Novel Tool to Support Engagement With Continuous Glucose Monitoring Systems and Optimize Outcomes.Journal of diabetes science and technology · 2020Article
- [Diabetes education and counselling in adult patients with diabetes (Update 2019)].Wiener klinische Wochenschrift · 2019Review
- Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System.Diabetes technology & therapeutics · 2019Article
- Analysis of "Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes".Journal of diabetes science and technology · 2019Article
- Review
- Future of Diabetes Technology.Journal of diabetes science and technology · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOptimal usage of continuous glucose monitoring (CGM) requires adequate training of the users. Providing patients with a CGM system without such a training usually doesn't lead to the intended improvement in metabolic control.
methodsIn Germany we developed a structured training program ("SPECTRUM") to ensure a high quality standard for the use of CGM systems.
resultsThis program is suitably for patients of all age groups and is applicable to all CGM systems and all forms of insulin therapy. A curriculum was also developed so that training centers with less experience with CGM could become capable of offering comprehensive CGM training.
conclusionsWe believe that usage of such a program can be an important step forward in achieving more widespread acceptance and use of CGM systems. Translations in other languages and evaluation with a controlled clinical trial are planned.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.